Get 15% off on Global Market Reports until March 31st! Use code FY25SAVE at checkout.
How has the veterinary renal disease market grown in recent years?
The market size for veterinary renal disease has been showing vigorous expansion in the past few years. The market which had a value of $15.5 billion in 2024 is projected to increase to $16.63 billion in 2025, forecasting a compound annual growth rate (CAGR) of 7.3%. Factors contributing to this growth during the historic phase include heightened initiatives aimed at disease awareness, a transition in consumer predilections towards natural and organic pet food, a rise in pet ownership rates worldwide, amendments in the regulations governing veterinary pharmaceuticals, and an increased awareness regarding pet health and nutrition.
How is the veterinary renal disease market size expected to evolve during the forecast period?
In the coming years, the veterinary renal disease market is projected to experience noteworthy expansion, with its size predicted to reach $21.74 billion in 2029 due to a compound annual growth rate (CAGR) of 6.9%. This growth, forecasted for the ensuing period, is attributable to developments such as the advent of individualized veterinary treatment, the extension of telemedicine and distant monitoring in veterinary services, an increase in veterinary clinical studies and research, the implementation of blockchain systems to ensure supply chain clarity in veterinary goods, and the merging of artificial intelligence with machine learning in veterinary diagnostic procedures. Upcoming trends for this forecasted period involve a rise in demand for veterinary teleconsultations, a spike in the adoption of customized dietary schedules for pets, the proliferation of pet’s health-monitoring wearables, veterinary telemedicine platform escalation, and the increasing application of precision medicine within veterinary oncology.
Get your veterinary renal disease market report here!
https://www.thebusinessresearchcompany.com/report/veterinary-renal-disease-global-market-report
Which key drivers are propelling the veterinary renal disease market’s growth?
The rise in pet ownership is predicted to boost the expansion of the veterinary renal disease market in the future. Conditions impacting an animal’s kidneys and potentially leading to symptoms such as elevated thirst, frequent urination, reduced appetite, and weight deterioration defines veterinary renal disease. The growth in such diseases is attributed to longer pet lifespans, exposure to toxins in the environment, dietary factors, and genetic predispositions. The standard treatments for pets with veterinary renal disease usually include dietary control, administration of medication, and fluid therapy to mitigate symptoms, hinder disease advancement, and augment the quality of life. As per Cooper Pet Care, a mobile pet care platform located in the Netherlands, by October 2022, the expected pet population in the European Union, inclusive of Norway and Switzerland, is about 145 million, a rise of 5 million from the 140 million pets in 2021. This population encompasses nearly 66 million dogs and 79 million cats. Consequently, the surge in pet ownership is propelling the growth of the veterinary renal disease market.
What are the market segments in the veterinary renal disease industry?
The veterinary renal disease market covered in this report is segmented –
1) By Type: Diagnosis, Treatment
2) By Animal Type: Canine, Feline, Bovine, Equine, Other Animal Types
3) By Indication: Renal Failure, Chronic Kidney Disease (CKD), Renal Cystitis, Kidney Stones, Nephritis, Other Indications
4) By Route of Administration: Injectable, Oral
5) By Distribution Channel: Pharmacies, Pet Specialty Stores, E-commerce, Other Distribution Channels
Subsegments:
1) By Diagnosis: Blood Tests, Urine Tests, Imaging, Biopsy
2) By Treatment: Medications, Dialysis, Kidney Transplantation, Fluid Therapy
Get your free sample now – explore exclusive market insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15957&type=smp
Who are the dominant players expanding their reach in the veterinary renal disease market?
Major companies operating in the veterinary renal disease market are Bayer HealthCare Animal Health Inc., Nestlé Purina PetCare Company, Zoetis Inc., Boehringer Ingelheim, Covetrus Inc., Elanco Animal Health Incorporated, Hill’s Pet Nutrition Inc., IDEXX Laboratories Inc., Ceva Santé Animale S.A., Dechra Pharmaceuticals PLC, Neogen Corporation, Vetoquinol S.A., Norbrook Laboratories Limited, Nutramax Laboratories Veterinary Sciences Inc., Animalcare Group plc, Antech Diagnostics Inc., Kindred Biosciences Inc., Vedco Inc., MSD Animal Health, Clinical Renal Associates, Veterinary Transplant Services Inc., Kibow Biotech Inc., Northwest Renal Clinic
What are the key trends shaping the future of the veterinary renal disease market?
Leading companies active in the market for renal disease in animals are prioritising the development of technological progress in treatments and diagnoses. New diagnostic tests, for instance, that can identify kidney injury even if clinical symptoms have not yet manifested. Such diagnostic tests aim to spot minute changes in renal function or form, which assists in early detection and intervention to avert developments to more serious stages of renal failure. IDEXX Laboratories Inc., a US-based organisation that creates and manufactures products and services for animals, launched the foremost veterinary diagnostic test for detecting kidney injury in cats and dogs in June 2023. This test, titled the IDEXX Cystatin B Test, has been designed to aid veterinary practitioners in spotting kidney injury before shifts in renal function become conspicuous, thereby improving patient outcomes. The IDEXX Cystatin B Test will be incorporated into panels testing for renal health, offering crucial knowledge during an approximated two million annual patient visits.
Unlock exclusive market insights – purchase your research report now for a swift delivery!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15957
Which regions are most influential in expanding the veterinary renal disease market?
North America was the largest region in the veterinary renal disease market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the veterinary renal disease market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
Browse Through More Similar Reports By The Business Research Company:
Veterinary Infectious Disease Diagnostics Global Market Report 2024
Veterinary Pain Management Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/veterinary-pain-management-global-market-report
Veterinary Active Pharmaceutical Ingredients Manufacturing Global Market Report 2024
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
